Related Experiment Video
Updated: Jul 4, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Duloxetine and suicide attempts: a possible relation
1Department of Psychiatry and Clinical Psychology, Saint George Hospital University Medical Center, Beirut, Lebanon. egkaram@idraac.org.
Summary
The use of Duloxetine may be linked to an increased risk of suicidal attempts, a connection not previously documented. Further research is needed to explore this potential antidepressant side effect.
Area of Science:
- Pharmacovigilance
- Neuroscience
- Clinical Psychiatry
Background:
- The relationship between antidepressant use and suicidal ideation remains a complex and debated topic in psychiatric research.
- While some antidepressants carry warnings for increased suicidal thoughts, specific associations with newer agents require ongoing investigation.
Purpose of the Study:
- To report two cases of suicidal attempts occurring during Duloxetine treatment.
- To highlight the potential, previously undocumented, association between Duloxetine and increased suicidality risk.
Main Methods:
- Case report methodology was employed.
- Clinical data from two patients experiencing suicidal attempts while on Duloxetine therapy were reviewed.
Main Results:
- Two distinct cases of suicidal attempts were observed during concomitant use of Duloxetine.
- No prior published literature documented a link between Duloxetine and an elevated risk of suicidality.
Conclusions:
- These cases suggest a potential association between Duloxetine and an increased risk of suicidal attempts.
- Further investigation and pharmacovigilance are warranted to clarify Duloxetine's role in suicidality.
Related Concept Videos
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...